Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression

Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression

Background: Complete pathological response to neoadjuvant treatment (NAT) in breast cancer is associated with prolonged survival. Compared to other breast cancer immunophenotypes, luminal tumors are the least chemosensitive with low rates of pathological response within this molecular subtype. Thus,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Isabel Miras, Ana Gil, Marta Benavent, María Ángeles Castilla, Begoña Vieites, María Ángeles Dominguez-Cejudo, Sonia Molina-Pinelo, Lina Alfaro, Javier Frutos, Manuel Ruiz-Borrego, Alejandro Falcón, Mónica Cejuela, Javier Salvador-Bofill
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-12-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359241309169
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry
by: Saiqa Nisar, et al.
Published: (2024-10-01)

Immunohistochemical Study of Ki-67 and HER2/neu and its Correlation with Clinicopathological Features in Surface Epithelial Tumors of the Ovary
by: Sameeksha Alva, et al.
Published: (2025-01-01)

ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment
by: A Ianza, et al.
Published: (2020-06-01)

Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters Expressão imunoistoquímica dos marcadores Ki-67, neun, sinaptofisina, p53 e HER2 em meduloblastoma e sua correlação com os parâmetros clínico-patológicos
by: Rosalva Thereza Meurer, et al.
Published: (2008-06-01)

Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer
by: Shane Mesko, et al.
Published: (2013-01-01)

P63 and Ki-67 expression in radicular cyst
by: Mohammed Amjed Alsaegh, et al.
Published: (2023-09-01)

Ki67 index importance in patients with breast cancer
by: O. Bondar
Published: (2024-12-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand
by: Phanchaporn Wongmaneerung, et al.
Published: (2025-02-01)

Marcadores biológicos: PCNA e Ki-67 breve revisão
by: Emilia Angela Loschiavo Arisawa, et al.
Published: (2010-07-01)

Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)

Immunohistochemical Staining Properties of Osteopontin and Ki-67 in Feline Meningiomas
by: Gabriele Gradner, et al.
Published: (2024-11-01)

Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus
by: Bernardo Silveira Volkweis, et al.
Published: (2012-01-01)

High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
by: Hossein Schandiz, et al.
Published: (2025-01-01)

The expression and significance of p53 protein and Ki-67 protein in pterygium
by: Ljubojević Vesna, et al.
Published: (2016-01-01)

Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023-12-01)

Maspin, Syndecan-1, and Ki-67 in the Odontogenic Keratocyst: An Immunohistochemical Analysis
by: Huda M. Hammad, et al.
Published: (2020-01-01)

Improving the accuracy of reporting Ki-67 IHC by using an AI tool
by: Sahil Ajit Saraf, et al.
Published: (2024-11-01)

Correlation of Ki-67 Expression with the Stage of Disease in Patients of Colorectal Carcinoma
by: Ashutosh Nagpal, et al.
Published: (2025-07-01)

Association between histologic grades and Ki67 score in breast cancer
by: Dr Shumaila Nawaz Khan Khan, et al.
Published: (2025-03-01)

The importance of Ki-67 proliferation index in small cell lung cancer
by: Seda Beyhan Sağmen, et al.
Published: (2025-01-01)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
by: Alexandra Schönherr, et al.
Published: (2004-01-01)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
by: Alper Sinanoglu, et al.
Published: (2015-06-01)

The impact of stratified management of Ki-67 on the prognosis of small-cell lung cancer
by: Xiaofang Zhang, et al.
Published: (2025-07-01)

A prognostic prediction model for advanced gastric cancer based on Ki67
by: NIU Linjun*，LI Xinzhong，LYU Yongjian
Published: (2025-07-01)

Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas
by: Rogelio González-González, et al.
Published: (2016-01-01)

A deep learning model to predict Ki-67 positivity in oral squamous cell carcinoma
by: Francesco Martino, et al.
Published: (2024-12-01)

Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study
by: Susnata Khan, et al.
Published: (2024-10-01)

Agreement between Ki-67 Proliferative Index in Breast Cancer by Conventional Hotspot Method and International Ki-67 in Breast Cancer Working Group Global Scoring Method: A Cross-sectional Study
by: Nidhi Radhakrishnan, et al.
Published: (2024-12-01)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.
by: Francesco Panzuto, et al.
Published: (2017-01-01)

Treatment of luminal HER2-negative breast cancer: opinion of experts
by: E. V. Artemeva, et al.
Published: (2024-06-01)

Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas
by: Zilan Luo, et al.
Published: (2025-12-01)

Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
by: Marković Olivera, et al.
Published: (2005-01-01)

Ki-67 promotes inflammatory signaling governing neutrophil recruitment during respiratory infections
by: Min Yee, et al.
Published: (2025-06-01)

CRP/albumin ratio and WBC values correlate with Ki-67 and survival in glioblastoma multiforme
by: Güven Gürsoy
Published: (2025-06-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
by: T. A. Bogush, et al.
Published: (2023-07-01)

Immununohistochemical Analysis of Progesterone Receptor and Ki-67 in Meningioma: A Cross-sectional Study
by: Rathin Hazra, et al.
Published: (2025-05-01)

Study of Immunohistochemical Expression of p53 and Ki-67 in Oral Squamous Cell Carcinoma
by: Kajal Ranjan, et al.
Published: (2025-08-01)

HPV–driven breast carcinogenesis: associations with tumor severity, Ki67 expression and metastasis
by: Usman Ayub Awan, et al.
Published: (2025-08-01)

Imaging‐Based Prediction of Ki‐67 Expression in Hepatocellular Carcinoma: A Retrospective Study
by: Chiyu Cai, et al.
Published: (2025-02-01)